[The Pancreas Study Group: Inhibition of pancreas secretion and trypsin activity. Mechanisms and importance of therapy of acute and chronic pancreatitis].
D000328:Adult; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology; D001639:Bicarbonates / Q000378:metabolism; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000378:metabolism; D002908:Chronic Disease; D004285:Dogs; D005260:Female; D016670:Gabexate; D006146:Guanidines / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007279:Injections, Subcutaneous; D008049:Lipase / Q000097:blood; D008297:Male; D015282:Octreotide; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism* / Q000648:ultrastructure; D010195:Pancreatitis / Q000188:drug therapy* / Q000503:physiopathology; D011949:Receptors, Cholecystokinin / Q000187:drug effects / Q000502:physiology; D012633:Secretin / Q000378:metabolism; D013004:Somatostatin / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D014357:Trypsin / Q000097:blood / Q000378:metabolism*
D001639:Bicarbonates; D006146:Guanidines; D011949:Receptors, Cholecystokinin; D012633:Secretin; D016670:Gabexate; D013004:Somatostatin; D002766:Cholecystokinin; D007611:Aprotinin; D008049:Lipase; D014357:Trypsin; D015282:Octreotide
Arbeitsgruppe "Pankreas": Hemmung der Pankreassekretion und der Trypsinaktivität. Wirkungsmechanismen und Bedeutung der Therapie der akuten und chronischen Pankreatitis.